Pfizer plots euro-sterling bond sale

Pfizer plans to sell a benchmark-sized four-part bond denominated in euros and sterling, one of the banks managing the sale said. Proceeds from the sale of the bonds, which will consist of four-year, seven-year and 12-year euro-denominated tranches and a 29-year sterling-denominated bond, will help fund its $68 billion takeover of Wyeth. Report